You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 124 No. 3, March 2006 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Clinical Trial
 •Online Features
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (27)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Public Health
 •World Health
 •Randomized Controlled Trial
 •Articles for Residents
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Single-Dose Azithromycin Prevents Trichiasis Recurrence Following Surgery

Randomized Trial in Ethiopia

Sheila K. West, PhD; Emily S. West, PhD; Wondu Alemayehu, MD, MPH; Muluken Melese, MD, MPH; Beatriz Munoz, MS; Alemush Imeru, MPH; Alemayehu Worku, MD; Charlotte Gaydos, DrPH, MS, MPH; Curtis L. Meinert, PhD; Thomas Quinn, MD

Arch Ophthalmol. 2006;124:309-314.

Background  Trichiasis recurrence following surgery is a serious problem for trachoma programs.

Objective  To determine if postoperative treatment with azithromycin compared with topical tetracycline reduces recurrence up to 1 year, and if azithromycin treatment of household members provides additional benefit compared with treating only the surgical patient.

Design  A randomized, single-masked, clinical trial was conducted in Ethiopia. A total of 1452 patients with trichiasis were randomized 1:1:1 to the following 3 arms: single-dose (1 g) oral azithromycin alone, single-dose azithromycin for household members (20 mg/kg up to 1 g) plus the patient, or topical tetracycline (twice per day for 6 weeks).

Main Outcome Measures  Trichiasis recurrence within 1 year following surgery.

Results  The combined azithromycin groups had significantly fewer recurrences, 6.9 of 100 person-years overall, compared with topical tetracycline, 10.3 of 100 person-years (P = .047). There was no additional reduction in the arm that also treated household members, 8.1 of 100 person-years, compared with treating the surgical patients alone, 5.8 of 100 person-years (P = .19).

Conclusions  In trachoma-endemic areas, a single dose of azithromycin reduced postoperative trichiasis recurrence rates by one third compared with topical tetracycline.

Application to Clinical Practice  In countries where azithromycin is part of the Trachoma Control Program, patients with trachomatous trichiasis should be treated postoperatively to prevent recurrence.


Author Affiliations: Dana Center for Preventive Ophthalmology, Wilmer Eye Institute (Drs S. West and E. West, Ms Munoz and Ms Imeru) and Department of Infectious Diseases (Drs Gaydos and Quinn), Johns Hopkins University, Baltimore, Md; ORBIS International, Addis Ababa, Ethiopia (Drs Alemayehu, Melese, and Worku); Center for Clinical Trials, Johns Hopkins Bloomberg School of Public Health, Baltimore, Md (Dr Meinert).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Three-Year Outcomes of the Surgery for Trichiasis, Antibiotics to Prevent Recurrence Trial
Woreta et al.
Arch Ophthalmol 2011;0:archophthalmol.2011.374v1-5.
ABSTRACT | FULL TEXT  

The Clinical Phenotype of Trachomatous Trichiasis in Ethiopia: Not All Trichiasis Is Due to Entropion
Rajak et al.
IOVS 2011;52:7974-7980.
ABSTRACT | FULL TEXT  

Adverse Events after Mass Azithromycin Treatments for Trachoma in Ethiopia
Ayele et al.
Am J Trop Med Hyg 2011;85:291-294.
ABSTRACT | FULL TEXT  

Rates and Risk Factors for Unfavorable Outcomes 6 Weeks after Trichiasis Surgery
Gower et al.
IOVS 2011;52:2704-2711.
ABSTRACT | FULL TEXT  

Bacterial Infection in Scarring Trachoma
Hu et al.
IOVS 2011;52:2181-2186.
ABSTRACT | FULL TEXT  

Quality assurance in trichiasis surgery: a methodology
Buchan et al.
Br J Ophthalmol 2011;95:331-334.
ABSTRACT | FULL TEXT  

Conjunctival Transcriptome in Scarring Trachoma
Burton et al.
Infect. Immun. 2011;79:499-511.
ABSTRACT | FULL TEXT  

Trichiasis Surgery in The Gambia: A 4-Year Prospective Study
Rajak et al.
IOVS 2010;51:4996-5001.
ABSTRACT | FULL TEXT  

Conjunctival Expression of Matrix Metalloproteinase and Proinflammatory Cytokine Genes after Trichiasis Surgery
Burton et al.
IOVS 2010;51:3583-3590.
ABSTRACT | FULL TEXT  

Effect of Trichiasis Surgery on Visual Acuity Outcomes in Ethiopia
Woreta et al.
Arch Ophthalmol 2009;127:1505-1510.
ABSTRACT | FULL TEXT  

Trachoma: an overview
Burton
Br Med Bull 2008;0:ldm034v1-18.
ABSTRACT | FULL TEXT  

Poverty and Human Development: Not a Stretch for Ophthalmology
West
Arch Ophthalmol 2007;125:1564-1565.
FULL TEXT  

Trachoma Control: Is Azithromycin the Answer for Trichiasis Too?
Lin and Lietman
Arch Ophthalmol 2007;125:819-820.
FULL TEXT  

Trachoma, antibiotics and randomised controlled trials.
Shapiro et al.
Br J Ophthalmol 2006;90:1443-1444.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.